Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atherogenesis in rheumatology.

S I van Leuven1, J J P Kastelein, D P D'Cruz

  • 1Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Lupus
|April 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021.

The British journal of dermatology·2021
Same author

High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events.

Atherosclerosis·2015
Same author

Proton pump inhibitor-induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus.

Clinical and experimental dermatology·2015
Same author

ApoA-I mimetics.

Handbook of experimental pharmacology·2014
Same author

Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.

Journal of the American Heart Association·2014
Same author

Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant.

Scandinavian journal of rheumatology·2014

Atherosclerosis involves chronic inflammation and plaque buildup. Other inflammatory conditions can accelerate atherosclerosis, increasing cardiovascular disease risk through shared and unique mechanisms.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Inflammation Biology

Background:

  • Atherosclerosis is a chronic inflammatory condition involving immune cell activation and plaque destabilization.
  • Chronic inflammation in other diseases is linked to accelerated atherosclerosis and increased cardiovascular disease (CVD) incidence.
  • Conditions like systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and antiphospholipid syndrome (APS) exemplify this link.

Purpose of the Study:

  • To explore the relationship between chronic inflammatory disorders and atherosclerosis.
  • To understand how systemic inflammation and specific disease mechanisms contribute to CVD risk.

Main Methods:

  • Review of existing literature on atherosclerosis and chronic inflammatory diseases.
  • Analysis of pathophysiological mechanisms linking inflammation to cardiovascular complications.

Related Experiment Videos

Main Results:

  • Chronic inflammatory states significantly accelerate the atherosclerotic process.
  • Increased CVD incidence is observed in patients with SLE, RA, and APS.
  • Both systemic inflammation and disorder-specific factors play roles in atherosclerosis development.

Conclusions:

  • Chronic inflammatory disorders represent a significant risk factor for atherosclerosis progression.
  • Targeting systemic inflammation and specific disease pathways may mitigate CVD risk in these patients.